| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/26/2001 | EP1136075A1 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 09/26/2001 | EP1136073A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 09/26/2001 | EP1136072A1 Preparations for intraurethral administration |
| 09/26/2001 | EP1135534A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases |
| 09/26/2001 | EP1135497A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 09/26/2001 | EP1135465A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 09/26/2001 | EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof |
| 09/26/2001 | EP1135411A1 Methods and compositions for treating disorders involving excitotoxicity |
| 09/26/2001 | EP1135406A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 |
| 09/26/2001 | EP1135393A2 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers |
| 09/26/2001 | EP1135381A1 Eletriptan hydrobromide monohydrate |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135374A1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/26/2001 | EP1135373A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative |
| 09/26/2001 | EP1135365A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction |
| 09/26/2001 | EP1135359A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135358A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135161A1 Chemotherapeutic composition and method |
| 09/26/2001 | EP1135158A2 Enhanced vaccines |
| 09/26/2001 | EP1135155A1 Methods of inhibiting ectopic calcification |
| 09/26/2001 | EP1135151A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 09/26/2001 | EP1135145A2 Isolated material having an anti-organotrophic effect |
| 09/26/2001 | EP1135144A1 Compositions and methods for regulating bacterial pathogenesis |
| 09/26/2001 | EP1135139A1 Micronized eplerenone compositions |
| 09/26/2001 | EP1135135A1 Chk1 kinase inhibitors |
| 09/26/2001 | EP1135131A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 09/26/2001 | EP1135128A2 Novel method of treatment |
| 09/26/2001 | EP1135123A1 Use of isatin derivatives as ion channel activating agents |
| 09/26/2001 | EP1135121A2 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| 09/26/2001 | EP1135116A1 Use of poly (hexamethylene) biguanide for producing an agent for promoting the healing of uninfected wounds |
| 09/26/2001 | EP1135112A1 An oral formulation for gastrointestinal drug delivery |
| 09/26/2001 | EP1135103A1 Use of plant extracts with an anti-radical-type action |
| 09/26/2001 | EP0800505B1 Novel immunotherapeutic aryl amides |
| 09/26/2001 | EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 09/26/2001 | EP0762887B1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 09/26/2001 | EP0738727B1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof |
| 09/26/2001 | CN1314943A Method for producing plants with increased flavonoid and phenolic compound content |
| 09/26/2001 | CN1314939A Inhibition of graft versus host disease |
| 09/26/2001 | CN1314914A Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 09/26/2001 | CN1314905A Muscarinic antagonists |
| 09/26/2001 | CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents |
| 09/26/2001 | CN1314895A Substituted piperazones and their therapeutic use |
| 09/26/2001 | CN1314893A IL-8 receptor antanonists |
| 09/26/2001 | CN1314890A Cyanoguanidines as cell proliferation inhibitors |
| 09/26/2001 | CN1314888A Crystalline forms of osanetant |
| 09/26/2001 | CN1314884A 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |
| 09/26/2001 | CN1314882A NAALADase inhibitors useful as pharmaceutical compound and compositions |
| 09/26/2001 | CN1314816A Low molecular weight compositions of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 09/26/2001 | CN1314811A Therapies for treating pulmonary diseases |
| 09/26/2001 | CN1314804A Improved stability for injection solutions |
| 09/26/2001 | CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 09/26/2001 | CN1314171A Traditional Chinese medicine preparation for regulating adolescence course and improving bone growth of sexual precocity child |
| 09/26/2001 | CN1314157A Traditional Chinese medicine for curing diabetes and kidney deficiency |
| 09/26/2001 | CN1314151A Use of AFMK in preparing medicine with free radical cloaning function |
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/26/2001 | CN1071752C Substituted thiophenesulfonylureas and-thioureas, processes for thei preparation, their use as medicament or diagnostic, and medicament containing them |
| 09/26/2001 | CN1071751C Reversible protease inhibitors |
| 09/26/2001 | CN1071743C Sulfuryl or sulfufiny/benzoyl guanidine derivative |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/26/2001 | CN1071570C Extended release, film-coated table of astemizole and pseudoephedrine |
| 09/25/2001 | US6294680 Process for the production of semi synthetic statins via novel intermediates |
| 09/25/2001 | US6294675 Chemical intermediate |
| 09/25/2001 | US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors |
| 09/25/2001 | US6294649 A cytotoxic peptide; therapy for breast cancer, brain tumor, kidney tumors; antitumor/antiproliferative/anticarcinogenic agents |
| 09/25/2001 | US6294586 Administering hydroxyomeprazole or its salt to human for therapy of ulcers |
| 09/25/2001 | US6294574 Compounds and methods for the treatment of inflammatory and immune disorders |
| 09/25/2001 | US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294564 Benzimidazoles and benzoxazoles |
| 09/25/2001 | US6294561 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294552 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294550 Treatment of female sexual dysfunction |
| 09/25/2001 | US6294546 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294538 Antidiabetic agents and diabetic neuropathy, treatment with oxidoreductase enzymes |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294530 Heterocyclic compounds for nervous system disorders |
| 09/25/2001 | US6294525 Reverse-turn mimetics and methods relating thereto |
| 09/25/2001 | US6294522 Compounds for treatment of cardiovascular disorders |
| 09/25/2001 | US6294350 Methods for treating fibroproliferative diseases |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | US6294168 Selectively binding said haloperoxidase to the pathogenic microbes, |
| 09/25/2001 | US6294165 Vectors and their use in gene transfer. based on retroviruses, adapted so that they cannot package their own rna, and which can be used as infectious agents to transfer foreign genes, e.g. for somatic gene therapy. |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/25/2001 | CA1341298C Human serum albumin fragment |
| 09/24/2001 | WO2003006652A2 Inhibition of specific histone deacetylase isoforms |
| 09/24/2001 | CA2408385A1 Inhibition of specific histone deacetylase isoforms |
| 09/20/2001 | WO2001069240A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068860A1 Antibodies to human cd154 |